WIRED @WIRED
A new obesity drug developed by Eolo Pharma is showing promise at burning fat without suppressing appetite in early trials. It could eventually be an alternative or add-on to popular GLP-1 medications.
https://t.co/Wapwy64ncX
https://t.co/Wapwy64ncX